The Global Antibiotic Resistance Market is estimated to be valued at US$ 8.83 Bn in 2024 and is expected to exhibit a CAGR of 5.4% over the forecast period 2024 To 2031 driven by increased R&D investments and fast-track approvals by regulatory bodies for new drugs to combat antibiotic resistance.Key TakeawaysKey players operating in the Global Antibiotic Resistance are Melinta Therapeutics,...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Russian
Romaian